한글목차

세계 병원용 스마트 웨어러블 시장 규모는 예측 기간 동안 연평균 14.3%의 높은 성장률을 기록할 것으로 예상됩니다.

지역별 분석

북미 시장은 심혈관 질환, 악성 종양, 당뇨병과 같은 진행성 질환의 우위성 확대, 병원용 웨어러블 기술의 발전, 지역적으로 뿌리 깊은 의료 서비스 체계로 인해 가장 큰 시장 점유율을 차지하고 있습니다.

아시아태평양 시장은 2022-2030년 가장 높은 성장률을 보일 것으로 예상됩니다. 이는 노령 인구의 증가, 의료 서비스 소비 증가, AI 기반 병원용 웨어러블의 확산에 기인합니다. 또한, 아시아 지역의 거대한 인구를 대표하는 노동 계급 가정의 가처분 소득이 증가하여 웰빙에 대한 진지한 지출이 증가함에 따라 이 지역의 시장 발전을 촉진하고 있습니다.

이 보고서는 세계 병원용 스마트 웨어러블 시장을 조사 분석했으며, 시장 역학, 지역 및 부문 분석, 기업 개요 등을 제공합니다.

목차

제1장 보고서 프롤로그

제2장 시장 서론

제3장 조사 방법

제4장 시장 역학

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회

제5장 시장 요인 분석

• Porter's Five Forces 분석
• 밸류체인 분석
• COVID-19의 영향 분석
  • 시장에 대한 영향 분석
  • 공급망에 대한 영향
  • 지역에 대한 영향
  • 기회와 위협 분석

제6장 세계의 병원용 스마트 웨어러블 시장 : 기기별

• 개요
• 진단·모니터링 기기
  • 바이탈 사인 모니터링 기기
  • 혈당 모니터링 기기
  • 신경 모니터링 기기
  • 수면 모니터링 기기
  • 기타
• 치료 기기
  • 통증 관리 기기
  • 재활 기기
  • 호흡요법 기기
  • 기타

제7장 세계의 병원용 스마트 웨어러블 시장 : 기술별

• 개요
• AI
• IoT
• 클라우드 컴퓨팅
• 기타

제8장 세계의 병원용 스마트 웨어러블 시장 : 유통 채널별

• 개요
• 약국
• 슈퍼마켓
• 온라인

제9장 세계의 병원용 스마트 웨어러블 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 영국
  • 기타 유럽
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타 아시아태평양
• 기타 지역
  • 중동
  • 아프리카
  • 라틴아메리카

제10장 기업 상황

• 경쟁 분석
• 시장 점유율 분석
• 세계의 병원용 스마트 웨어러블 시장의 주요 성장 전략
• 경쟁 벤치마킹
• 세계의 병원용 스마트 웨어러블 시장의 개발수 주요 기업

제11장 기업 개요

• BOSTON SCIENTIFIC CORPORATION
• HONEYWELL INTERNATIONAL INC.
• OMRON CORPORATION
• MEDTRONIC
• KONINKLIJKE PHILIPS N.V.
• SOTERA, INC.
• SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
• BIOINTELLISENSE, INC.
• VITALCONNECT
• MEDIOTEK HEALTH SYSTEMS

제12장 부록

영문목차

Market Overview

The smart hospital wearables market is projected to register a significant CAGR of 14.3% during the forecast period. Expanded reception of smart hospital wearable gadgets to support market development. Smart hospital wearable gadgets are smart gadgets worn on the body that screen and track various crucial signs, for example, circulatory strain, pulse, and oxygen levels. These gadgets help in the observation of different ailments, for example, rest problems, diabetes, and lung illnesses. The blend of man-made reasoning (computer-based intelligence), AI, and digitalization in hospital wearable gadgets assists with continuous admittance to patient well-being information, worked on quiet results, and further developed proficiency and clinical staff limit. Besides, the developing reception of new advances and expanded web entrance set out open doors for the players associated with the market. Nonetheless, rising information security concerns and high gadget expenses might obstruct the Smart Hospital Wearables Market's development.

There are different advantages of smart hospital wearable gadgets. They are more useful to patients experiencing persistent sicknesses, as these patients are bound to get long-haul clinical consideration and are bound to visit trauma centers. These smart wearable gadgets are coordinated with state-of-the-art innovations like the Web of Things, permitting medical services experts to screen patients and give more far-reaching care. There are different sorts of smart hospital wearable gadgets, for example, wearable biosensors, wearable ECG screens, and wearable circulatory strain screens.

Market Segmentation

Diagnostic & monitoring devices and therapeutic devices are included in the market segments for smart hospital wearables. The vital sign monitoring devices, blood glucose monitoring devices, neuromonitoring devices, sleep monitoring devices, and others subsegment the diagnostic & monitoring devices market. The therapeutic devices category is further broken down into sub-segmented respiratory therapy, rehabilitation, pain management, and other uses.

The market is divided into categories based on technology including cloud computing, artificial intelligence, and the Internet of Things.

The global market for smart hospital wearables has been divided into three categories based on distribution channels: pharmacies, hypermarkets, and online.

Regional Analysis

The development of the North American smart hospital wearables market is credited to mechanical progressions in hospital wearable gadgets and the deep-rooted medical services foundation in the region.

North American market of smart hospital wearables represents the biggest piece of the pie because of the expanded predominance of ongoing illnesses like cardiovascular problems, malignant growth, and diabetes, mechanical progressions in hospital wearable gadgets, and deep-rooted medical services framework in the region.

The Asia-Pacific smart hospital wearables market is supposed to develop at most elevated rate from 2022 to 2030. This is because of the rising geriatric populace, the ascent in medical services consumption, and the rising reception of artificial intelligence-empowered hospital wearables. Besides, the rising extra cash of working-class families, which represent a huge populace in Asia, empowering serious spending on wellbeing, is driving the market development of smart hospital wearables in the region.

Major Players

The key players in the market are Boston Scientific Corporation (US), Sotera, Inc. (US), Omron Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), MediaTek Health Systems (India), VitalConnect (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Honeywell International Inc. (US), and BioIntelliSense, Inc. (US).

TABLE OF CONTENTS

TABLE OF CONTENTS

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTIONS
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING TECHNIQUES
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1. BARGAINING POWER OF SUPPLIERS
  • 5.1.2. BARGAINING POWER OF BUYERS
  • 5.1.3. THREAT OF NEW ENTRANTS
  • 5.1.4. THREAT OF SUBSTITUTES
  • 5.1.5. INTENSITY OF RIVALRY
• 5.2. VALUE CHAIN ANALYSIS
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. MARKET IMPACT ANALYSIS
  • 5.3.2. IMPACT ON SUPPLY CHAIN
  • 5.3.3. REGIONAL IMPACT
  • 5.3.4. OPPORTUNITY AND THREAT ANALYSIS

6. GLOBAL SMART HOSPITAL WEARABLES MARKET, BY DEVICE

• 6.1. OVERVIEW
• 6.2. DIAGNOSTIC & MONITORING DEVICES
  • 6.2.1. VITAL SIGN MONITORING DEVICES
  • 6.2.2. GLUCOSE MONITORING DEVICES
  • 6.2.3. NEUROMONITORING DEVICES
  • 6.2.4. SLEEP MONITORING DEVICES
  • 6.2.5. OTHERS
• 6.3. THERAPEUTIC DEVICES
  • 6.3.1. PAIN MANAGEMENT DEVICES
  • 6.3.2. REHABILITATION DEVICES
  • 6.3.3. RESPIRATORY THERAPY DEVICES
  • 6.3.4. OTHERS

7. GLOBAL SMART HOSPITAL WEARABLES MARKET, BY TECHNOLOGY

• 7.1. OVERVIEW
• 7.2. ARTIFICIAL INTELLIGENCE
• 7.3. INTERNET OF THINGS
• 7.4. CLOUD COMPUTING
• 7.5. OTHERS

8. GLOBAL SMART HOSPITAL WEARABLES MARKET, BY DISTRIBUTION CHANNEL

• 8.1. OVERVIEW
• 8.2. PHARMACIES
• 8.3. HYPERMARKETS
• 8.4. ONLINE

9. GLOBAL SMART HOSPITAL WEARABLES MARKET, BY REGION

• 9.1. OVERVIEW
• 9.2. NORTH AMERICA
  • 9.2.1. US
  • 9.2.2. CANADA
• 9.3. EUROPE
  • 9.3.1. GERMANY
  • 9.3.2. FRANCE
  • 9.3.3. ITALY
  • 9.3.4. SPAIN
  • 9.3.5. UK
  • 9.3.6. REST OF EUROPE
• 9.4. ASIA-PACIFIC
  • 9.4.1. JAPAN
  • 9.4.2. CHINA
  • 9.4.3. INDIA
  • 9.4.4. AUSTRALIA
  • 9.4.5. SOUTH KOREA
  • 9.4.6. REST OF ASIA-PACIFIC
• 9.5. REST OF THE WORLD
  • 9.5.1. MIDDLE EAST
  • 9.5.2. AFRICA
  • 9.5.3. LATIN AMERICA

10. COMPANY LANDSCAPE

• 10.1. OVERVIEW
• 10.2. COMPETITIVE ANALYSIS
• 10.3. MARKET SHARE ANALYSIS
• 10.4. MAJOR GROWTH STRATEGY IN THE GLOBAL SMART HOSPITAL WEARABLES MARKET
• 10.5. COMPETITIVE BENCHMARKING
• 10.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL SMART HOSPITAL WEARABLES MARKET
• 10.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 10.7.1. NEW PRODUCT LAUNCH
  • 10.7.2. MERGER & ACQUISITIONS
  • 10.7.3. JOINT VENTURES
• 10.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 10.8.1. SALES & OPERATING INCOME, 2021
  • 10.8.2. MAJOR PLAYERS R&D EXPENDITURE, 2021

11. COMPANY PROFILES

• 11.1. BOSTON SCIENTIFIC CORPORATION
  • 11.1.1. COMPANY OVERVIEW
  • 11.1.2. PRODUCTS OFFERED
  • 11.1.3. FINANCIAL OVERVIEW
  • 11.1.4. KEY DEVELOPMENTS
  • 11.1.5. SWOT ANALYSIS
  • 11.1.6. KEY STRATEGIES
• 11.2. HONEYWELL INTERNATIONAL INC.
  • 11.2.1. COMPANY OVERVIEW
  • 11.2.2. PRODUCTS OFFERED
  • 11.2.3. FINANCIAL OVERVIEW
  • 11.2.4. KEY DEVELOPMENTS
  • 11.2.5. SWOT ANALYSIS
  • 11.2.6. KEY STRATEGIES
• 11.3. OMRON CORPORATION
  • 11.3.1. COMPANY OVERVIEW
  • 11.3.2. PRODUCTS OFFERED
  • 11.3.3. FINANCIAL OVERVIEW
  • 11.3.4. KEY DEVELOPMENTS
  • 11.3.5. SWOT ANALYSIS
  • 11.3.6. KEY STRATEGIES
• 11.4. MEDTRONIC
  • 11.4.1. COMPANY OVERVIEW
  • 11.4.2. PRODUCTS OFFERED
  • 11.4.3. FINANCIAL OVERVIEW
  • 11.4.4. KEY DEVELOPMENTS
  • 11.4.5. SWOT ANALYSIS
  • 11.4.6. KEY STRATEGIES
• 11.5. KONINKLIJKE PHILIPS N.V.
  • 11.5.1. COMPANY OVERVIEW
  • 11.5.2. PRODUCTS OFFERED
  • 11.5.3. FINANCIAL OVERVIEW
  • 11.5.4. KEY DEVELOPMENTS
  • 11.5.5. SWOT ANALYSIS
  • 11.5.6. KEY STRATEGIES
• 11.6. SOTERA, INC.
  • 11.6.1. COMPANY OVERVIEW
  • 11.6.2. PRODUCTS OFFERED
  • 11.6.3. FINANCIAL OVERVIEW
  • 11.6.4. KEY DEVELOPMENTS
  • 11.6.5. SWOT ANALYSIS
  • 11.6.6. KEY STRATEGIES
• 11.7. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • 11.7.1. COMPANY OVERVIEW
  • 11.7.2. PRODUCTS OFFERED
  • 11.7.3. FINANCIAL OVERVIEW
  • 11.7.4. KEY DEVELOPMENTS
  • 11.7.5. SWOT ANALYSIS
  • 11.7.6. KEY STRATEGIES
• 11.8. BIOINTELLISENSE, INC.
  • 11.8.1. COMPANY OVERVIEW
  • 11.8.2. PRODUCTS OFFERED
  • 11.8.3. FINANCIAL OVERVIEW
  • 11.8.4. KEY DEVELOPMENTS
  • 11.8.5. SWOT ANALYSIS
  • 11.8.6. KEY STRATEGIES
• 11.9. VITALCONNECT
  • 11.9.1. COMPANY OVERVIEW
  • 11.9.2. PRODUCTS OFFERED
  • 11.9.3. FINANCIAL OVERVIEW
  • 11.9.4. KEY DEVELOPMENTS
  • 11.9.5. SWOT ANALYSIS
  • 11.9.6. KEY STRATEGIES
• 11.10. MEDIOTEK HEALTH SYSTEMS
  • 11.10.1. COMPANY OVERVIEW
  • 11.10.2. PRODUCTS OFFERED
  • 11.10.3. FINANCIAL OVERVIEW
  • 11.10.4. KEY DEVELOPMENTS
  • 11.10.5. SWOT ANALYSIS
  • 11.10.6. KEY STRATEGIES

12. APPENDIX

• 12.1. REFERENCES
• 12.2. RELATED REPORTS